PROLONGED THERAPY WITH BORTEZOMIB PLUSMELPHALAN-PREDNISONE (VMP) RESULTS IN IMPROVED QUALITYAND DURATION OF RESPONSE IN THE PHASE III VISTA STUDY INPREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM)

Abstract

Abstract is not available.

    Similar works